Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Bosch

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Journal of Hepatology|October 4, 2021
Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?Gyorgy Baffy, Jaume Bosch
Nature Reviews. Gastroenterology & Hepatology|May 13, 2015
Therapy. Statins and liver disease: from concern to 'wonder' drugs?Jaume Bosch, Xavier Forns
Annals of Internal Medicine|July 19, 2021
Web Exclusive. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Hepatorenal SyndromeElliot B Tapper, Jaume Bosch
Nature Reviews. Gastroenterology & Hepatology|January 27, 2025
Preventing the progression of cirrhosis to decompensation and deathCàndid Villanueva, Dhiraj Tripathi, Jaume Bosch
Hepatology (Baltimore, Md.)|June 9, 2004
Monitoring of HVPG during pharmacological therapy: evidence in favor of the prognostic value of a 20% reductionJuan Carlos Garcia-Pagán, Jaume Bosch
Journal of Hepatology|May 26, 2004
The resistance of the cirrhotic liver: a new target for the treatment of portal hypertension. 1985Juan Carlos García-Pagán, Jaume Bosch
Lancet (London, England)|March 22, 2003
Prevention of variceal rebleedingJaume Bosch, Juan Carlos García-Pagán
Hepatology (Baltimore, Md.)|May 25, 2013
Regarding “Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution”Annalisa Berzigotti, Juan G Abraldes, Jaume Bosch
Alimentary Pharmacology & Therapeutics|December 8, 2022
Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' replyChiara Becchetti, Melisa Dirchwolf, Annalisa Berzigotti, et al.
Journal of Hepatology|February 27, 2023
Reply to: "Carvedilol in patients with compensated cirrhosis: The ongoing benefits of definitive randomised trials over meta-analysis in patients with small varices"Càndid Villanueva, Ferran Torres, Dhiraj Tripathi, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|October 4, 2021
Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?Gyorgy Baffy, Jaume Bosch
Nature Reviews. Gastroenterology & Hepatology|May 13, 2015
Therapy. Statins and liver disease: from concern to 'wonder' drugs?Jaume Bosch, Xavier Forns
Annals of Internal Medicine|July 19, 2021
Web Exclusive. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Hepatorenal SyndromeElliot B Tapper, Jaume Bosch
Nature Reviews. Gastroenterology & Hepatology|January 27, 2025
Preventing the progression of cirrhosis to decompensation and deathCàndid Villanueva, Dhiraj Tripathi, Jaume Bosch
Hepatology (Baltimore, Md.)|June 9, 2004
Monitoring of HVPG during pharmacological therapy: evidence in favor of the prognostic value of a 20% reductionJuan Carlos Garcia-Pagán, Jaume Bosch
Journal of Hepatology|May 26, 2004
The resistance of the cirrhotic liver: a new target for the treatment of portal hypertension. 1985Juan Carlos García-Pagán, Jaume Bosch
Lancet (London, England)|March 22, 2003
Prevention of variceal rebleedingJaume Bosch, Juan Carlos García-Pagán
Hepatology (Baltimore, Md.)|May 25, 2013
Regarding “Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution”Annalisa Berzigotti, Juan G Abraldes, Jaume Bosch
Alimentary Pharmacology & Therapeutics|December 8, 2022
Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' replyChiara Becchetti, Melisa Dirchwolf, Annalisa Berzigotti, et al.
Journal of Hepatology|February 27, 2023
Reply to: "Carvedilol in patients with compensated cirrhosis: The ongoing benefits of definitive randomised trials over meta-analysis in patients with small varices"Càndid Villanueva, Ferran Torres, Dhiraj Tripathi, et al.
Pageof 14